[Pharma & Biotech News] Personalized mRNA Cancer Vaccine Development Accelerates: Nature Biotechnology Review
A comprehensive review published in the June 2025 issue of Nature Biotechnology summarizes the current status of personalized mRNA cancer vaccine development. Neoantigen-based mRNA vaccines, tailored to individual patients' tumor mutatio...